Page 17 - Layout 1
P. 17

PREVENTATIVE
                                                                                                   MEDICINE









           d.) Vaginal cancer: Often pres-
              ents like cervical cancer with
              painless vaginal discharge,
              vaginal bleeding or bleeding
              after intercourse. With disease
              progression, these symptoms
              can include urinary symptoms such
              as dysuria, urinary retention or hema-
              turia. Continuing disease progression can
              lead to gastrointestinal issues such as colonic ob-
              struction or bloody stools.
           e.) Vulvar cancer: Vulvar cancer often presents with an enlarg-
              ing vulvar bump or lump that can be pigmented, or ulcerated
              and it can itch, burn or bleed.

        4.) Can cancer risk be reduced, if so, how?
          Women with a strong family history of breast and/or ovarian cancer
        who have genetic testing and found to have a high-risk genetic muta-
        tion (such as BRCA1/2, Lynch syndrome, RAD51C/D, BRIP1) can
        undergo risk reducing surgery with removal of the ovaries and fallopian
        tubes to markedly reduce the risk of developing ovarian, fallopian tube
        or primary peritoneal cancer. Patients with obesity and irregular peri-
        ods can reduce the risk of developing endometrial cancer by losing
        weight and taking contraceptives that promote regular periods. Certain
        patients, such as those with Lynch syndrome should undergo risk re-
        ducing surgery to remove the uterus and cervix, along with the ovaries
        and fallopian tubes when they are done with childbearing but usually
        no sooner than age 35-40 to reduce the risk of endometrial and ovarian
        cancer. HPV vaccination of young girls can reduce the risk of develop-
        ing cervical cancer, vaginal cancer or vulvar cancer as these are often as-
        sociated with HPV infection.

        References
        1.) ACOG Practice Bulletin on Hereditary Breast and Ovarian Cancer
           Syndromes
        2.) ACOG Practice Bulletin on Lynch Syndrome
        3.) Onstad MA, Schmandt RE, Lu KH. Addressing the Role of Obe-
           sity in Endometrial Cancer Risk, Prevention, and Treatment. J Clin
           Oncol. 2016;34(35):4225-4230. doi:10.1200/JCO.2016.69.4638
        4.) Eskander, R. N., & Bristow, R. E. (2014). Gynecologic Oncology:
           A Pocketbook (2015th ed.). Springer.

                 Jaron Mark, MD is a Gynecologic Oncologist Surgeon with
                 the START Center. He is a member of the Bexar County
                 Medical Society.


                                                                                             Visit us at www.bcms.org     17
   12   13   14   15   16   17   18   19   20   21   22